Scarica l'app Stockscreener
206.23
0.77%
-1.605
Precedente Chiudi:
$207.84
Aprire:
$208.83
Volume 24 ore:
790.44K
Relative Volume:
0.62
Capitalizzazione di mercato:
$28.76B
Reddito:
$2.12B
Utile/perdita netta:
$-309.19M
Rapporto P/E:
-90.29
EPS:
-2.2841
Flusso di cassa netto:
$93.57M
1 W Prestazione:
+1.57%
1M Prestazione:
-13.31%
6M Prestazione:
+30.77%
1 anno Prestazione:
+20.79%
Intervallo 1D:
$204.04
$213.30
Intervallo di 1 settimana:
$203.86
$214.36
Portata 52W:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
206.23 | 28.98B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Iniziato | Citigroup | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-27 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Prenatal Testing Co. Missed Fatal Condition, Couple Say - Law360
Krilogy Financial LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Allspring Growth Fund Q4 2025 Fund Performers And Detractors - Seeking Alpha
Envestnet Asset Management Inc. Purchases 17,254 Shares of Natera, Inc. $NTRA - MarketBeat
How Natera Inc. stock trades before earnings2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? - 富途牛牛
Natera Inc (NTRA) Trading 3.93% Higher on Feb 9 - GuruFocus
Natera's Signatera test to be covered under Medicare - MSN
Earnings Miss: What are analysts price targets for Natera Inc2025 Market Overview & Pattern Based Trade Signal System - baoquankhu1.vn
Natera, Inc. $NTRA Shares Sold by Savant Capital LLC - MarketBeat
Is Natera (NTRA) Quietly Redefining Its Moat With Multi-Front Cell-Free DNA Expansion? - simplywall.st
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes - Yahoo Finance
AGF Management Ltd. Sells 6,300 Shares of Natera, Inc. $NTRA - MarketBeat
This brand-new Peninsula building sat vacant for a year. Now it's landed two big tenants - The Business Journals
News | Genetic testing firm inks deal at Silicon Valley life science campus - CoStar
C WorldWide Group Holding A S Decreases Stock Position in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Purchased by Thrivent Financial for Lutherans - MarketBeat
Natera CEO sells $20.7 million in NTRA stock By Investing.com - Investing.com South Africa
Natera sec. and chief legal officer sells $307k in stock By Investing.com - Investing.com Nigeria
Natera sec. and chief legal officer sells $307k in stock - Investing.com UK
Natera director Sheena Jonathan sells $100k in stock By Investing.com - Investing.com Australia
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 4,725 Shares - MarketBeat
Natera (NASDAQ:NTRA) Insider Sells $378,232.03 in Stock - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera files Signatera CDx PMA with FDA for bladder cancer MRD test - MSN
Natera CFO Brophy sells $1.58 million in NTRA stock By Investing.com - Investing.com Canada
Natera Inc: President Moshkevich sells $1.07 million in NTRA stock By Investing.com - Investing.com Nigeria
Natera (NASDAQ:NTRA) Insider Sells $830,285.88 in Stock - MarketBeat
Natera Inc. president Fesko sells $830k in stock By Investing.com - Investing.com Nigeria
Natera CEO sells $20.7 million in NTRA stock - Investing.com
Natera Inc: President Moshkevich sells $1.07 million in NTRA stock - Investing.com
Oversold Conditions For Natera (NTRA) - Nasdaq
Natera Inc (NTRA) Stock Price Down 7.82% on Feb 4 - GuruFocus
Principal Financial Group Inc. Has $69.11 Million Stake in Natera, Inc. $NTRA - MarketBeat
National Pension Service Invests $1.49 Million in Natera, Inc. $NTRA - MarketBeat
Trading Systems Reacting to (NTRA) Volatility - Stock Traders Daily
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test - The Globe and Mail
Exploring US High Growth Tech Stocks This February 2026 - simplywall.st
Natera submits FDA approval for bladder cancer test By Investing.com - Investing.com Nigeria
Natera Files FDA PMA for Signatera CDx in Muscle-Invasive Bladder Cancer - Oncodaily
Natera, Inc. (NTRA) Stock Analysis: Potential Growth Amidst Strong Analyst Confidence - DirectorsTalk Interviews
FDA premarket approval sought for Signatera CDx test in MIBC - Urology Times
Natera Submits Signatera™ CDx PMA to FDA - MEXC
Natera Submits Premarket Approval Application for Molecular Residual Disease Test Signatera CDx - marketscreener.com
NTRA Submits PMA to FDA for Bladder Cancer Detection Innovation - GuruFocus
Natera submits Signatera(TM) CDx PMA to FDA - marketscreener.com
Natera submits FDA approval for bladder cancer test - Investing.com
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.13%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):